Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 2
2000 1
2001 2
2003 2
2004 5
2005 5
2006 4
2007 2
2009 4
2010 3
2011 5
2012 2
2013 1
2014 3
2015 4
2016 4
2017 3
2018 1
2019 5
2020 5
2021 2
2022 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C, Antoniotti C, Rossini D, Lonardi S, Loupakis F, Pietrantonio F, Bordonaro R, Latiano TP, Tamburini E, Santini D, Passardi A, Marmorino F, Grande R, Aprile G, Zaniboni A, Murgioni S, Granetto C, Buonadonna A, Moretto R, Corallo S, Cordio S, Antonuzzo L, Tomasello G, Masi G, Ronzoni M, Di Donato S, Carlomagno C, Clavarezza M, Ritorto G, Mambrini A, Roselli M, Cupini S, Mammoliti S, Fenocchio E, Corgna E, Zagonel V, Fontanini G, Ugolini C, Boni L, Falcone A; GONO Foundation Investigators. Cremolini C, et al. Among authors: cordio s. Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9. Lancet Oncol. 2020. PMID: 32164906 Free article. Clinical Trial.
Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association.
Salvatore L, Imperatori M, Arnoldi E, Carnaghi C, Cordio S, Cosimelli M, Cremolini C, Maiello E, Martinelli E, Normanno N, Sciallero S, Cannizzaro R, Musio D, Cinquini M, Moschetti I, Fittipaldo VA, Aprile G, Beretta GD. Salvatore L, et al. Among authors: cordio s. ESMO Open. 2020 Dec;5(6):e001001. doi: 10.1136/esmoopen-2020-001001. ESMO Open. 2020. PMID: 33262200 Free PMC article. Review.
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.
Reni M, Giommoni E, Bergamo F, Milella M, Cavanna L, Di Marco MC, Spada M, Cordio S, Aprile G, Cardellino GG, Maiello E, Bernardini I, Ghidini M, Bozzarelli S, Macchini M, Orsi G, De Simone I, Rulli E, Porcu L, Torri V, Pinto C; GARIBALDI Study Group. Reni M, et al. Among authors: cordio s. ESMO Open. 2023 Feb;8(1):100777. doi: 10.1016/j.esmoop.2022.100777. Epub 2023 Feb 1. ESMO Open. 2023. PMID: 36731325 Free PMC article.
Bevacizumab Plus Chemotherapy Cost Effectiveness.
Bordonaro R, Cordio S, Uccello M, Martines C, Fassari GE. Bordonaro R, et al. Among authors: cordio s. J Clin Oncol. 2015 Nov 10;33(32):3840-1. doi: 10.1200/JCO.2015.62.0195. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304880 No abstract available.
Fludarabine, mitoxantrone and dexamethasone as front-line therapy in elderly patients affected by newly-diagnosed, low-grade non-Hodgkin's lymphomas with unfavorable prognostic factors: results of a phase II study.
Bordonaro R, Petralia G, Restuccia N, Todaro AM, Serraino D, Giuffrida D, Cordio S, Giannitto-Giorgio C, Salice P, Ursino M, Novello G, Marletta F, Manusia M. Bordonaro R, et al. Among authors: cordio s. Leuk Lymphoma. 2004 Jan;45(1):93-100. doi: 10.1080/1042819031000139765. Leuk Lymphoma. 2004. PMID: 15061203 Clinical Trial.
62 results